t:slim X2 Insulin Pump
Say goodbye to outdated pump technology
Enjoy more freedom managing your diabetes with the t:slim X2 insulin pump. The sleek design is matched with a host of advanced features you expect in a modern device.
The Choice is Easy
The t:slim X2 insulin pump can be used as a standalone insulin pump, or you can integrate it with the Dexcom G6 continuous glucose monitoring (CGM) system.* When used with CGM, you can choose one of two predictive insulin delivery technologies.
Control-IQ Technology
Control-IQ advanced hybrid closed-loop technology adjusts insulin delivery to help prevent highs and lows, while still allowing the user to manually bolus for meals.Basal-IQ Technology
Basal-IQ technology predicts and helps reduce the frequency and duration of low-glucose events. This system operates in the background without constant input.Powerful Features
The beauty of the t:slim X2 insulin pump is that it is up to 38% smaller than other pumps,† yet it can hold a surprisingly large amount of insulin (up to 300 units). With its colour touchscreen, the t:slim X2 pump is also easy to read and intuitive to use for anyone familiar with a smart device.
Zero Fingersticks
When integrated with Dexcom G6 CGM‡
Custom Settings
Create up to six Personal Profiles
Rechargeable Battery
Convenient charging via micro-USB port
Watertight Construction
Tested to 0.91 meters for 30 minutes (IPX7 rating)
Tandem Diabetes Care is the only company that allows its users to remotely update the software of their in‑warranty t:slim X2 insulin pump with new capabilities as additional features become available.§
Infusion Sets
Finding the right infusion set is an important part of successful insulin pump therapy, which is why we offer different options.
AutoSoft 90: 90-degree soft cannula
AutoSoft 30: 30-degree soft cannula
VariSoft: Variable angle soft cannula
TruSteel: 90-degree steel needle
t:simulator Application
Explore the interface of the t:slim X2 pump with our free demo app
Click the badges below to visit the download page for your device.
Support Resources
Responsible Use of Predictive Technologies
Systems like the t:slim X2 insulin pump with Basal-IQ technology and the t:slim X2 insulin pump with Control-IQ technology are not substitutes for active diabetes management. For example, users still must bolus for meals. Basal-IQ technology is designed to predict and help prevent lows, but it cannot prevent all lows and Basal-IQ technology does not predict high glucose events. Control-IQ technology is designed to predict and help prevent low and high glucose events, but it cannot prevent all highs and lows, and Control-IQ requires that users accurately input information, such as meals and periods of sleep or exercise. The Basal-IQ and Control-IQ features rely on continuous CGM readings and will not be able to predict glucose levels and adjust insulin dosing if your CGM is not working properly or is unable to communicate with your pump. Be sure to always use your pump, cartridges, CGM, and infusion sets as instructed and check them regularly to make sure they are working properly. Always pay attention to your symptoms, actively monitor your glucose levels, and treat according to your healthcare provider’s recommendations.
* Dexcom CGM sold separately.
† 38% smaller than MiniMed 770G. Data on file, Tandem Diabetes Care.
‡ Zero fingersticks required when using the t:slim X2 pump with Dexcom G6 CGM integration. If glucose alerts and CGM readings do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.
§ Additional feature updates are not currently available for the t:slim X2 insulin pump with Control-IQ technology. Control-IQ technology is available only to customers who reside in the United States or Canada, and other select geographies. Future updates for all or some of Tandem’s products may not be developed and may not be offered everywhere and would be subject to applicable regulatory approvals. Software updates are only available to customers who are in warranty at the time they update their pump. Additional training may be required to access certain future software updates. Charges may apply. Tandem may discontinue select software and features over time at its discretion.
Important Safety Information
RX ONLY. The t:slim X2 insulin pump, Basal-IQ technology, and Control-IQ technology are intended for single patient use. The t:slim X2 pump, Basal-IQ technology, and Control-IQ technology are indicated for use with U-100 insulin only.
t:slim X2 insulin pump: The t:slim X2 insulin pump with interoperable technology is an alternate controller enabled (ACE) pump that is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in people requiring insulin. The pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices. The pump is indicated for use in individuals six years of age and greater. Basal-IQ technology: Basal-IQ technology is intended for use with a compatible integrated continuous glucose monitor (iCGM, sold separately) and ACE pump to automatically suspend delivery of insulin based on iCGM readings and predicted glucose values. The bolus calculator is indicated for the management of diabetes by people with diabetes by calculating an insulin dose or carbohydrate intake based on user entered data. Basal-IQ technology is intended for the management of diabetes mellitus in persons six years of age and greater. Control-IQ technology: Control-IQ technology is intended for use with a compatible iCGM (sold separately) and ACE pump to automatically increase, decrease, and suspend delivery of basal insulin based on iCGM readings and predicted glucose values. It can also deliver correction boluses when the glucose value is predicted to exceed a predefined threshold. Control-IQ technology is intended for the management of Type 1 diabetes mellitus in persons six years of age and greater.
Warning: Control-IQ technology should not be used by anyone under the age of six years old. It should also not be used in patients who require less than 10 units of insulin per day or who weigh less than 55 pounds.
Control-IQ technology and Basal-IQ technology are not indicated for use in pregnant women, people on dialysis, or critically ill patients. Do not use Control-IQ technology if using hydroxyurea. Users of the t:slim X2 pump, Basal-IQ technology, and Control-IQ technology must: be able and willing to use the insulin pump, CGM, and all other system components in accordance with their respective instructions for use; test blood glucose levels as recommended by their healthcare provider; demonstrate adequate carb-counting skills; maintain sufficient diabetes self-care skills; see healthcare provider(s) regularly; and have adequate vision and/or hearing to recognize all functions of the pump, including alerts, alarms, and reminders. The t:slim X2 pump, transmitter, and sensor must be removed before MRI, CT, or diathermy treatment. Visit www.tandemdiabetes.com/safetyinfo for additional important safety information.